Changes in the oxidative balance can affect cellular physiology and adaptation through redox signaling. The endothelial cells that line blood vessels are particularly sensitive to reactive oxygen species, which can alter cell function by a number of mechanisms, including the oxidative post-translational modification (oxPTM) of proteins on critical cysteine thiols. Such modifications can act as redox-switches to alter the function of targeted proteins.
Recent Advances:
Mapping the cysteine oxPTM proteome and characterizing the effects of individual oxPTMs to gain insight into consequences for cellular responses has proven challenging. A recent addition to the list of reversible oxPTMs that contributes to cellular redox homeostasis is persulfidation or S-sulfhydration.
Critical Issues:
It has been estimated that up to 25% of proteins are S-sulfhydrated, making this modification almost as abundant as phosphorylation. In the endothelium, persulfides are generated by the trans-sulfuration pathway that catabolizes cysteine and cystathionine to generate hydrogen sulfide (H2S) and H2S-related sulfane sulfur compounds (H2Sn). This pathway is of particular importance for the vascular system, as the enzyme cystathionine γ lyase (CSE) in endothelial cells accounts for a significant portion of total vascular H2S/H2Sn production.
Future Directions:
Impaired CSE activity in endothelial dysfunction has been linked with marked changes in the endothelial cell S-sulfhydrome and can contribute to the development of atherosclerosis and hypertension. It will be interesting to determine how changes in the S-sulfhydration of specific networks of proteins contribute to endothelial cell physiology and pathophysiology. Antioxid. Redox Signal. 35, 1494–1514.
AkterS, FuL, JungY, Lo ConteM, LawsonJR, LowtherWT, SunR, LiuK, YangJ, and CarrollKS. Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat Chem Biol, 14: 995–1004, 2018.
3.
AltaanyZ, JuY, YangG, and WangR. The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide. Sci Signal, 7: ra87, 2014.
4.
AnandP and StamlerJS. Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. J Mol Med, 90: 233–244, 2012.
5.
BanerjeeR, ChikuT, KabilO, LibiadM, MotlN, and YadavPK. Assay methods for H2S biogenesis and catabolism enzymes. Methods Enzymol, 554: 189–200, 2015.
6.
BeedleAEM, LynhamS, and Garcia-ManyesS. Protein S-sulfenylation is a fleeting molecular switch that regulates non-enzymatic oxidative folding. Nat Commun, 7: 12490, 2016.
BenitezLV and AllisonWS. The inactivation of the acyl phosphatase activity catalyzed by the sulfenic acid form of glyceraldehyde 3-phosphate dehydrogenase by dimedone and olefins. J Biol Chem, 249: 6234–6243, 1974.
9.
BhatiaM and GaddamRR. Hydrogen sulfide in inflammation: a novel mediator and therapeutic target. Antioxid Redox Signal, 34: 1368–1377, 2021.
BibliS-I, HuJ, LoosoM, WeigertA, RatiuC, WittigJ, DrekoliaMK, TomborL, RandriamboavonjyV, LeisegangMS, GoymannP, Delgado LagosF, FisslthalerB, ZukunftS, KyselovaA, JustoAFO, HeidlerJ, TsilimigrasD, BrandesRP, DimmelerS, PapapetropoulosA, KnappS, OffermannsS, WittigI, NishimuraSL, SigalaF, and FlemingI. Mapping the endothelial cell S-sulfhydrome highlights the crucial role of integrin Sulfhydration in Vascular Function. Circulation, 143: 935–948, 2021.
12.
BibliS-I, HuJ, SigalaF, WittigI, HeidlerJ, ZukunftS, TsilimigrasDI, RandriamboavonjyV, WittigJ, KojonazarovB, SchürmannC, SiragusaM, SiudaD, LuckB, Abdel MalikR, FilisKA, ZografosG, ChenC, WangDW, PfeilschifterJ, BrandesRP, SzaboC, PapapetropoulosA, and FlemingI. Cystathionine γ lyase sulfhydrates the RNA binding protein human antigen R to preserve endothelial cell function and delay atherogenesis. Circulation, 139: 101–114, 2019.
13.
BosEM, WangR, SnijderPM, BoersemaM, DammanJ, FuM, MoserJ, HillebrandsJ-L, PloegRJ, YangG, LeuveninkHGD, and van GoorH. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol, 24: 759–770, 2013.
14.
BrandesN, SchmittS, and JakobU. Thiol-based redox switches in eukaryotic proteins. Antioxid Redox Signal, 11: 997–1014, 2009.
15.
BucciM, VelleccoV, CantalupoA, BrancaleoneV, ZhouZ, EvangelistaS, CalderoneV, PapapetropoulosA, and CirinoG. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Cardiovasc Res, 102: 138–147, 2014.
16.
ButawanM, BenjaminRL, and BloomerRJ. Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients, 9: 290, 2017.
17.
ButturiniE, Carcereri de PratiA, and MariottoS. Redox regulation of STAT1 and STAT3 signaling. Int J Mol Sci, 21: 7034, 2020.
18.
ButturiniE, CozzolinoF, BorieroD, Carcereri de PratiA, MontiM, RossinM, CanettiD, CelliniB, PucciP, and MariottoS. S-glutathionylation exerts opposing roles in the regulation of STAT1 and STAT3 signaling in reactive microglia. Free Radic Biol Med, 117: 191–201, 2018.
19.
CalderoneV, MartelliA, TestaiL, CitiV, and BreschiMC. Using hydrogen sulfide to design and develop drugs. Expert Opin Drug Discov, 11: 163–175, 2016.
20.
CarballalS, TrujilloM, CuevasantaE, BartesaghiS, MöllerMN, FolkesLK, García-BereguiaínMA, Gutiérrez-MerinoC, WardmanP, DenicolaA, RadiR, and AlvarezB. Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic Biol Med, 50: 196–205, 2011.
21.
CayrolC and GirardJ-P. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev, 281: 154–168, 2018.
22.
ChiappettaG, NdiayeS, IgbariaA, KumarC, VinhJ, and ToledanoMB. Proteome screens for Cys residues oxidation: the redoxome. Methods Enzymol, 473: 199–216, 2010.
23.
ChungHS, WangS-B, VenkatramanV, MurrayCI, and van EykJE. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res, 112: 382–392, 2013.
24.
CicconeV, GenahS, and MorbidelliL.Endothelium as a source and target of H2S to improve its trophism and function. Antioxidants, 10, 486, 2021.
25.
CitiV, MartelliA, GoricaE, BrogiS, TestaiL, and CalderoneV. Role of hydrogen sulfide in endothelial dysfunction: pathophysiology and therapeutic approaches. J Adv Res, 27: 99–113, 2021.
26.
CleurenAC, van der EntMA, JiangH, HunkerKL, YeeA, SiemieniakDR, MolemaG, AirdWC, GaneshSK, GinsburgD, and CleurenACA. The in vivo endothelial cell translatome is highly heterogeneous across vascular beds. Proc Natl Acad Sci USA, 116: 23618–23624, 2019.
ConklinDJ, HaberzettlP, ProughRA, and BhatnagarA. Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am J Physiol Heart Circ Physiol, 296: H1586–H1597, 2009.
29.
CremersCM and JakobU. Oxidant sensing by reversible disulfide bond formation. J Biol Chem, 288: 26489–26496, 2013.
30.
CuiX, LuYW, LeeV, KimD, DorseyT, WangQ, LeeY, VincentP, SchwarzJ, and DaiG. Venous endothelial marker COUP-TFII regulates the distinct pathologic potentials of adult arteries and veins. Sci Rep, 5: 16193, 2015.
31.
DaZhang, DuJ, TangC, HuangY, and JinH. H2S-Induced sulfhydration: biological function and detection methodology. Front Pharmacol, 8: 608, 2017.
32.
Dalle-DonneI, RossiR, ColomboG, GiustariniD, and MilzaniA. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci, 34: 85–96, 2009.
33.
DaviesMJ.The oxidative environment and protein damage. Biochim Biophys Acta, 1703: 93–109, 2005.
34.
DaviesPF, CivelekM, FangY, and FlemingI. The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo. Cardiovasc Res, 99: 315–327, 2013.
35.
DavisME, CaiH, DrummondGR, and HarrisonDG. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res, 89: 1073–1080, 2001.
36.
D'ImprimaE, MillsDJ, PareyK, BrandtU, KühlbrandtW, ZickermannV, and VonckJ. Cryo-EM structure of respiratory complex I reveals a link to mitochondrial sulfur metabolism. Biochim Biophys Acta, 1857: 1935–1942, 2016.
37.
DoellerJE, IsbellTS, BenavidesG, KoenitzerJ, PatelH, PatelRP, LancasterJR, Darley-UsmarVM, and KrausDW. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem, 341: 40–51, 2005.
38.
DouliasP-T, GreeneJL, GrecoTM, TenopoulouM, SeeholzerSH, DunbrackRL, and IschiropoulosH. Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc Natl Acad Sci USA, 107: 16958–16963, 2010.
39.
DouliasP-T, TenopoulouM, GreeneJL, RajuK, and IschiropoulosH. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci Signal, 6: rs1, 2013.
40.
Dyballa-RukesN, JakobsP, EckersA, Ale-AghaN, SerbuleaV, AufenvenneK, ZschauerT-C, RabanterLL, JakobS, AmelnF von, EckermannO, LeitingerN, GoyC, AltschmiedJ, and HaendelerJ. The anti-apoptotic properties of APEX1 in the endothelium require the first 20 amino acids and converge on thioredoxin-1. Antioxid Redox Signal, 26: 616–629, 2017.
41.
FangY, WuD, and BirukovKG. Mechanosensing and mechanoregulation of endothelial cell functions. Compr Physiol, 9: 873–904, 2019.
42.
FengS, ChenS, YuW, DaZhang, ZhangC, TangC, DuJ, and JinH. H2S inhibits pulmonary arterial endothelial cell inflammation in rats with monocrotaline-induced pulmonary hypertension. Lab Invest, 97: 268–278, 2017.
43.
FilipovicMR, ZivanovicJ, AlvarezB, and BanerjeeR. Chemical biology of H2S signaling through persulfidation. Chem Rev, 118: 1253–1337, 2018.
FlemingI, FisslthalerB, DixitM, and BusseR. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci, 118: 4103–4111, 2005.
47.
FormanHJ, ZhangH, and RinnaA. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med, 30: 1–12, 2009.
FuL, LiuK, HeJ, TianC, YuX, and YangJ. Direct proteomic mapping of cysteine persulfidation. Antioxid Redox Signal: 1061–1076, 2020.
50.
FuX, ZhaiS, and YuanJ. Endothelial HuR deletion reduces the expression of proatherogenic molecules and attenuates atherosclerosis. Int Immunopharmacol, 65: 248–255, 2018.
51.
FujiwaraN, NakanoM, KatoS, YoshiharaD, OokawaraT, EguchiH, TaniguchiN, and SuzukiK. Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem, 282: 35933–35944, 2007.
52.
GaoX-H, LiL, ParisienM, WuJ, BedermanI, GaoZ, KrokowskiD, ChirieleisonSM, AbbottD, WangB, ArvanP, CameronM, ChanceM, WillardB, and HatzoglouM. Discovery of a redox thiol switch: implications for cellular energy metabolism. Mol Cell Proteomics, 19: 852–870, 2020.
53.
GerőD, TorregrossaR, PerryA, WatersA, Le-TrionnaireS, WhatmoreJL, WoodM, and WhitemanM. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res, 113: 186–198, 2016.
54.
GiuffrèA and VicenteJB. Hydrogen sulfide biochemistry and interplay with other gaseous mediators in mammalian physiology. Oxid Med Cell Longev, 2018: 6290931, 2018.
55.
GoY-M, DuongDM, PengJ, and JonesDP. Protein cysteines map to functional networks according to steady-state level of oxidation. J Proteomics Bioinform, 4: 196–209, 2011.
56.
Gonzalez BoscLV, OsmondJM, GiermakowskaWK, PaceCE, RiggsJL, Jackson-WeaverO, and KanagyNL. NFAT regulation of cystathionine γ-lyase expression in endothelial cells is impaired in rats exposed to intermittent hypoxia. Am J Physiol Heart Circ Physiol, 312: H791–H799, 2017.
57.
GouldNS, EvansP, Martínez-AcedoP, MarinoSM, GladyshevVN, CarrollKS, and IschiropoulosH. Site-specific proteomic mapping identifies selectively modified regulatory cysteine residues in functionally distinct protein networks. Chem Biol, 22: 965–975, 2015.
58.
GruneT, ReinheckelT, and DaviesKJ. Degradation of oxidized proteins in mammalian cells. FASEB J, 11: 526–534, 1997.
59.
GuptaV and CarrollKS. Sulfenic acid chemistry, detection and cellular lifetime. Biochim Biophys Acta, 1840: 847–875, 2014.
60.
HartleMD and PluthMD. A practical guide to working with H2S at the interface of chemistry and biology. Chem Soc Rev, 45: 6108–6117, 2016.
61.
HöhnTJA and GruneT. The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system. Redox Biol, 2: 388–394, 2014.
62.
HuH-J, JiangZ-S, ZhouS-H, and LiuQ-M. Hydrogen sulfide suppresses angiotensin II-stimulated endothelin-1 generation and subsequent cytotoxicity-induced endoplasmic reticulum stress in endothelial cells via NF-κB. Mol Med Rep, 14: 4729–4740, 2016.
63.
HuiY, DuJ, TangC, BinG, and JiangH. Changes in arterial hydrogen sulfide (H2S) content during septic shock and endotoxin shock in rats. J Infect, 47: 155–160, 2003.
64.
IwakiriY, SatohA, ChatterjeeS, ToomreDK, ChalouniCM, FultonD, GroszmannRJ, ShahVH, and SessaWC. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci USA, 103: 19777–19782, 2006.
65.
JungS-B, KimC-S, KimY-R, NaqviA, YamamoriT, KumarS, KumarA, and IraniK. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain. PLoS One, 8: e65415, 2013.
66.
KanagyNL, SzaboC, and PapapetropoulosA. Vascular biology of hydrogen sulfide. Am J Physiol Cell Physiol, 312: C537–C549, 2017.
67.
Kang-DeckerN, CaoS, ChatterjeeS, YaoJ, EganLJ, SemelaD, MukhopadhyayD, and ShahV. Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J Cell Sci, 120: 492–501, 2007.
68.
KaraliE, BellouS, StellasD, KlinakisA, MurphyC, and FotsisT. VEGF signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Mol Cell, 54: 559–572, 2014.
69.
KimuraY, GotoY-I, and KimuraH. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal, 12: 1–13, 2010.
70.
KondoK, BhushanS, KingAL, PrabhuSD, HamidT, KoenigS, MuroharaT, PredmoreBL, GojonG, WangR, KarusulaN, NicholsonCK, CalvertJW, and LeferDJ. H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation, 127: 1116–1127, 2013.
71.
KrönckeK-D and KlotzL-O. Zinc fingers as biologic redox switches?. Antioxid Redox Signal, 11: 1015–1027, 2009.
72.
LeeS-J, KimK-M, NamkoongS, KimC-K, KangY-C, LeeH, HaK-S, HanJ-A, ChungH-T, KwonY-G, and KimY-M. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem, 280: 5781–5788, 2005.
73.
LefflerCW, ParfenovaH, BasuroyS, JaggarJH, UmstotES, and FedinecAL. Hydrogen sulfide and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol, 300: H440–H447, 2011.
74.
LermantA and MurdochCE. Cysteine glutathionylation acts as a redox switch in endothelial cells. Antioxidants, 8: 315, 2019.
75.
LevittMD, Abdel-RehimMS, and FurneJ. Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxid Redox Signal, 15: 373–378, 2011.
76.
LiL, WhitemanM, GuanYY, NeoKL, ChengY, LeeSW, ZhaoY, BaskarR, TanC-H, and MoorePK. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation, 117: 2351–2360, 2008.
77.
LiQ and LancasterJR. Chemical foundations of hydrogen sulfide biology. Nitric Oxide, 35: 21–34, 2013.
LiuZ, HanY, LiL, LuH, MengG, LiX, ShirhanM, PehMT, XieL, ZhouS, WangX, ChenQ, DaiW, TanC-H, PanS, MoorePK, and JiY. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E-/- mice. Br J Pharmacol, 169: 1795–1809, 2013.
80.
Lo BelloM, NuccetelliM, CaccuriAM, StellaL, ParkerMW, RossjohnJ, McKinstryWJ, MozziAF, FedericiG, PolizioF, PedersenJZ, and RicciG. Human glutathione transferase P1-1 and nitric oxide carriers; a new role for an old enzyme. J Biol Chem, 276: 42138–42145, 2001.
81.
Lo Conte M and CarrollKS.The redox biochemistry of protein sulfenylation and sulfinylation. J Biol Chem, 288: 26480–26488, 2013.
LongenS, RichterF, KöhlerY, WittigI, BeckK-F, and PfeilschifterJ. Quantitative persulfide site identification (qPerS-SID) reveals protein targets of H2S releasing donors in mammalian cells. Sci Rep, 6: 29808, 2016.
84.
LorenzonP, VecileE, NardonE, FerreroE, HarlanJM, TedescoF, and DobrinaA. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J Cell Biol, 142: 1381–1391, 1998.
85.
LuM, HuL-F, HuG, and BianJ-S. Hydrogen sulfide protects astrocytes against H2O2-induced neural injury via enhancing glutamate uptake. Free Radic Biol Med, 45: 1705–1713, 2008.
86.
LvB, ChenS, TangC, JinH, DuJ, and HuangY. Hydrogen sulfide and vascular regulation - An update. J Adv Res, 27: 85–97, 2021.
87.
ManiS, LiH, UntereinerA, WuL, YangG, AustinRC, DickhoutJG, Lhoták Š, MengQH, and WangR. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation, 127: 2523–2534, 2013.
88.
MarinoSM and GladyshevVN. Analysis and functional prediction of reactive cysteine residues. J Biol Chem, 287: 4419–4425, 2012.
89.
MatsuiR, WatanabeY, and MurdochCE. Redox regulation of ischemic limb neovascularization - What we have learned from animal studies. Redox Biol, 12: 1011–1019, 2017.
90.
MatsumotoH, HaniuH, and KomoriN. Determination of protein molecular weights on SDS-PAGE. Methods Mol Biol, 1855: 101–105, 2019.
91.
MatsushitaK, MorrellCN, CambienB, YangSX, YamakuchiM, BaoC, HaraMR, QuickRA, CaoW, O'RourkeB, LowensteinJM, PevsnerJ, WagnerDD, and LowensteinCJ. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell, 115: 139–150, 2003.
92.
MehtaV, PangK-L, RozbeskyD, NatherK, KeenA, LachowskiD, KongY, KariaD, AmeismeierM, HuangJ, FangY, Del Rio HernandezA, ReaderJS, JonesEY, and TzimaE. The guidance receptor plexin D1 is a mechanosensor in endothelial cells. Nature, 578: 290–295, 2020.
93.
MengG, ZhaoS, XieL, HanY, and JiY. Protein S-sulfhydration by hydrogen sulfide in cardiovascular system. Br J Pharmacol, 175: 1146–1156, 2018.
94.
MistryRK, MurrayTVA, PrysyazhnaO, MartinD, BurgoyneJR, SantosC, EatonP, ShahAM, and BrewerAC. Transcriptional regulation of cystathionine-γ-lyase in endothelial cells by NADPH oxidase 4-dependent signaling. J Biol Chem, 291: 1774–1788, 2016.
95.
MódisK, ColettaC, ErdélyiK, PapapetropoulosA, and SzaboC. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J, 27: 601–611, 2013.
96.
MódisK, JuY, AhmadA, UntereinerAA, AltaanyZ, WuL, SzaboC, and WangR. S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics. Pharmacol Res, 113: 116–124, 2016.
97.
MohammadiS, NajafiM, HamzeiyH, Maleki-DizajiN, PezeshkianM, Sadeghi-BazarganiH, DarabiM, MostafalouS, BohlooliS, and GarjaniA. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats. Adv Pharmacol Sci, 2012: 507278, 2012.
98.
MontiM, TerzuoliE, ZicheM, and MorbidelliL. The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis. Pharmacol Res, 76: 171–181, 2013.
99.
MontiM, TerzuoliE, ZicheM, and MorbidelliL. H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall. Pharmacol Res, 113: 426–437, 2016.
100.
MortazE, TabarsiP, MansouriD, KhosraviA, GarssenJ, VelayatiA, and AdcockIM. Cancers related to immunodeficiencies: update and perspectives. Front Immunol, 7: 365, 2016.
MuzaffarS, JeremyJY, SparatoreA, Del SoldatoP, AngeliniGD, and ShuklaN. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol, 155: 984–994, 2008.
104.
NadanakaS, OkadaT, YoshidaH, and MoriK. Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol Cell Biol, 27: 1027–1043, 2007.
105.
NagyP.Mechanistic chemical perspective of hydrogen sulfide signaling. Methods Enzymol, 554: 3–29, 2015.
106.
NichollsP and KimJK. Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system. Can J Biochem, 60: 613–623, 1982.
107.
NichollsP.The formation and properties of sulphmyoglobin and sulphcatalase. Biochem J, 81: 374–383, 1961.
108.
NieH, JuH, FanJ, ShiX, ChengY, CangX, ZhengZ, DuanX, and YiW. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun, 11: 36, 2020.
109.
OguriT, SchneiderB, and ReitzerL. Cysteine catabolism and cysteine desulfhydrase (CdsH/STM0458) in Salmonella enterica serovar typhimurium. J Bacteriol, 194: 4366–4376, 2012.
110.
OjedaPG, ChanLY, PothAG, WangCK, and CraikDJ. The role of disulfide bonds in structure and activity of chlorotoxin. Future Med Chem, 6: 1617–1628, 2014.
111.
OliveiraCJR, CurcioMF, MoraesMS, TsujitaM, TravassosLR, SternA, and MonteiroHP. The low molecular weight S-nitrosothiol, S-nitroso-N-acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide, 18: 241–255, 2008.
112.
OlsonKR.H2S and polysulfide metabolism: conventional and unconventional pathways. Biochem Pharmacol, 149: 77–90, 2018.
113.
OlsonKR.Are Reactive sulfur species the new reactive oxygen species?. Antioxid Redox Signal, 33: 1125–1142, 2020.
114.
OlsonKR, GaoY, DeLeonER, ArifM, ArifF, AroraN, and StraubKD. Catalase as a sulfide-sulfur oxido-reductase: an ancient (and modern?) regulator of reactive sulfur species (RSS). Redox Biol, 12: 325–339, 2017.
115.
PajaresM, CuadradoA, EngedalN, JirsovaZ, and CahovaM. The role of free radicals in autophagy regulation: implications for ageing. Oxid Med Cell Longev, 2018: 2450748, 2018.
116.
PajaresM, Jiménez-MorenoN, DiasIHK, DebelecB, VuceticM, FladmarkKE, BasagaH, RibaricS, MilisavI, and CuadradoA. Redox control of protein degradation. Redox Biol, 6: 409–420, 2015.
117.
PastoreA and PiemonteF. Protein glutathionylation in cardiovascular diseases. Int J Mol Sci, 14: 20845–20876, 2013.
118.
PaulBD and SnyderSH. H₂S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol, 13: 499–507, 2012.
119.
PaulBD, SnyderSH, and KashfiK. Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics. Redox Biol, 38: 101772, 2021.
120.
PaulsenCE and CarrollKS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev, 113: 4633–4679, 2013.
121.
PernaAF, SepeI, LanzaD, CapassoR, ZappavignaS, CapassoG, CaragliaM, and IngrossoD. Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation. J Cell Biochem, 114: 1536–1548, 2013.
122.
PiX, WuY, FergusonJE, PortburyAL, and PattersonC. SDF-1α stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration. Proc Natl Acad Sci USA, 106: 5675–5680, 2009.
123.
PietriR, Román-MoralesE, and López-GarrigaJ. Hydrogen sulfide and hemeproteins: knowledge and mysteries. Antioxid Redox Signal, 15: 393–404, 2011.
124.
PolhemusDJ, LiZ, PattilloCB, GojonG, GiordanoT, and KrumH. A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients. Cardiovasc Ther, 33: 216–226, 2015.
125.
PooleLB.Formation and functions of protein sulfenic acids. Curr Protoc Toxicol Chapter 17: Unit17.1, 2004.
126.
PooleLB.The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med, 80: 148–157, 2015.
127.
PooleLB and NelsonKJ. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol, 12: 18–24, 2008.
128.
PowellCR, DillonKM, and MatsonJB. A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications. Biochem Phyrmacol, 149: 110–123, 2018.
129.
RashdanNA, ShresthaB, and PattilloCB. S-glutathionylation, friend or foe in cardiovascular health and disease. Redox Biol, 37: 101693, 2020.
130.
ReddieKG and CarrollKS. Expanding the functional diversity of proteins through cysteine oxidation. Curr Opin Chem Biol, 12: 746–754, 2008.
131.
RidkerPM, EverettBM, ThurenT, MacFadyenJG, ChangWH, BallantyneC, FonsecaF, NicolauJ, KoenigW, AnkerSD, KasteleinJJP, CornelJH, PaisP, PellaD, GenestJ, CifkovaR, LorenzattiA, ForsterT, KobalavaZ, Vida-SimitiL, FlatherM, ShimokawaH, OgawaH, DellborgM, RossiPRF, TroquayRPT, LibbyP, and GlynnRJ. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. New Eng J Med, 377: 1119–1131, 2017.
132.
RohlenovaK, GoveiaJ, García-CaballeroM, SubramanianA, KaluckaJ, TrepsL, FalkenbergKD, RooijLPMH de, ZhengY, LinL, SokolL, TeuwenL-A, GeldhofV, TavernaF, PircherA, ConradiL-C, KhanS, StegenS, PanovskaD, SmetF de, StaalFJT, MclaughlinRJ, VinckierS, van BergenT, EctorsN, HaesP de, WangJ, BolundL, SchoonjansL, KarakachTK, YangH, CarmelietG, LiuY, ThienpontB, DewerchinM, EelenG, LiX, LuoY, and CarmelietP. Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab, 31: 862–877.e14, 2020.
133.
RoosG, FoloppeN, and MessensJ. Understanding the pK(a) of redox cysteines: the key role of hydrogen bonding. Antioxid Redox Signal, 18: 94–127, 2013.
134.
RoosG and MessensJ. Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radic Biol Med, 51: 314–326, 2011.
135.
RoseP, MoorePK, WhitemanM, KirkC, and ZhuY-Z. Diet and hydrogen sulfide production in mammals. Antioxid Redox Signal, 34: 1378–1393, 2021.
136.
RushingAM, DonnarummaE, PolhemusDJ, AuKR, VictoriaSE, SchumacherJD, LiZ, JenkinsJS, LeferDJ, and GoodchildTT. Effects of a novel hydrogen sulfide prodrug in a porcine model of acute limb ischemia. J Vasc Surg, 69: 1924–1935, 2019.
SenN, PaulBD, GadallaMM, MustafaAK, SenT, XuR, KimS, and SnyderSH. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell, 45: 13–24, 2012.
139.
SenaCM, LeandroA, AzulL, SeiçaR, and PerryG. Vascular oxidative stress: impact and therapeutic approaches. Front Physiol, 9: 1668, 2018.
140.
ShakirS, VinhJ, and ChiappettaG. Quantitative analysis of the cysteine redoxome by iodoacetyl tandem mass tags. Anal Bioanal Chem, 409: 3821–3830, 2017.
141.
ShibuyaN, KoikeS, TanakaM, Ishigami-YuasaM, KimuraY, OgasawaraY, FukuiK, NagaharaN, and KimuraH. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun, 4: 1366, 2013.
142.
SikorskiK, ChmielewskiS, PrzybylL, HeemannU, WesolyJ, BaumannM, and BluyssenHAR. STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. Am J Physiol Cell Physiol, 300: C1337–C1344, 2011.
SmolyarovaDD, PodgornyOV, BilanDS, and BelousovVV.A guide to genetically encoded tools for the study of H2O2. FEBS J, 2021. [Epub ahead of print]; DOI: 10.1111/febs.16088.
145.
SoutourinaJ, BlanquetS, and PlateauP. Role of D-cysteine desulfhydrase in the adaptation of Escherichia coli to D-cysteine. J Biol Chem, 276: 40864–40872, 2001.
146.
SpragueAH and KhalilRA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol, 78: 539–552, 2009.
StamlerJS, TooneEJ, LiptonSA, and SucherNJ. (S)NO signals: translocation, regulation, and a consensus motif. Neuron, 18: 691–696, 1997.
149.
StarkeDW, ChockPB, and MieyalJJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Biol Chem, 278: 14607–14613, 2003.
150.
SteigerAK, ZhaoY, and PluthMD. Emerging roles of carbonyl sulfide in chemical biology: sulfide transporter or gasotransmitter?. Antioxid Redox Signal, 28: 1516–1532, 2018.
151.
SteinhublSR.Why have antioxidants failed in clinical trials?. Am J Cardiol, 101: 14D–19D, 2008.
StomberskiCT, HessDT, and StamlerJS. Protein S-nitrosylation: determinants of specificity and enzymatic regulation of S-nitrosothiol-based signaling. Antioxid Redox Signal, 30: 1331–1351, 2019.
154.
SunH-J, WuZ-Y, NieX-W, and BianJ-S. Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide. Front Pharmacol, 10: 1568, 2019.
155.
SunH-J, XiongS-P, CaoX, CaoL, ZhuM-Y, WuZ-Y, and BianJ-S. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3. Redox Biol, 38: 101813, 2021.
156.
SunM-A, ZhangQ, WangY, GeW, and GuoD. Prediction of redox-sensitive cysteines using sequential distance and other sequence-based features. BMC Bioinformatics, 17: 316, 2016.
157.
SunW-H, LiuF, ChenY, and ZhuY-C. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun, 421: 164–169, 2012.
158.
SuoR, ZhaoZ-Z, TangZ-H, RenZ, LiuX, LiuL-S, WangZ, TangC-K, WeiD-H, and JiangZ-S. Hydrogen sulfide prevents H₂O₂-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Mol Med Rep, 7: 1865–1870, 2013.
159.
SuzukiK, OlahG, ModisK, ColettaC, KulpG, GeröD, SzoleczkyP, ChangT, ZhouZ, WuL, WangR, PapapetropoulosA, and SzaboC. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA, 108: 13829–13834, 2011.
SzaboC and PapapetropoulosA. International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors. Pharmacol Rev, 69: 497–564, 2017.
162.
SzmitkoPE, WangC-H, WeiselRD, AlmeidaJR de, AndersonTJ, and VermaS. New markers of inflammation and endothelial cell activation: Part I. Circulation, 108: 1917–1923, 2003.
163.
TellG, QuadrifoglioF, TiribelliC, and KelleyMR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal, 11: 601–620, 2009.
164.
TerzuoliE, MontiM, VelleccoV, BucciM, CirinoG, ZicheM, and MorbidelliL. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2S availability. Br J Pharmacol, 172: 2961–2973, 2015.
165.
TewKD and TownsendDM. Glutathione-s-transferases as determinants of cell survival and death. Antioxid Redox Signal, 17: 1728–1737, 2012.
166.
ThibeaultS, RautureauY, OubahaM, FaubertD, WilkesBC, DelisleC, and GrattonJ-P. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell, 39: 468–476, 2010.
167.
TomasovaL, PavlovicovaM, MalekovaL, MisakA, KristekF, GrmanM, CacanyiovaS, TomasekM, TomaskovaZ, PerryA, WoodME, LacinovaL, OndriasK, and WhitemanM. Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels. Nitric Oxide, 46: 131–144, 2015.
168.
TzimaE, del PozoMA, ShattilSJ, ChienS, and SchwartzMA. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J, 20: 4639–4647, 2001.
169.
TzimaE, Irani-TehraniM, KiossesWB, DejanaE, SchultzDA, EngelhardtB, CaoG, DeLisserH, and SchwartzMA. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature, 437: 426–431, 2005.
170.
van der ReestJ, LillaS, ZhengL, ZanivanS, and GottliebE. Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress. Nat Commun, 9: 1581, 2018.
171.
WangG, MoniriNH, OzawaK, StamlerJS, and DaakaY. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci USA, 103: 1295–1300, 2006.
WangR, SzaboC, IchinoseF, AhmedA, WhitemanM, and PapapetropoulosA. The role of H2S bioavailability in endothelial dysfunction. Trends Pharmacol Sci, 36: 568–578, 2015.
174.
WangY, YangJ, and YiJ. Redox sensing by proteins: oxidative modifications on cysteines and the consequent events. Antioxid Redox Signal, 16: 649–657, 2012.
175.
WaniR, NagataA, and MurrayBW. Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology. Front Pharmacol, 5: 224, 2014.
176.
WatanabeY, MurdochCE, SanoS, IdoY, BachschmidMM, CohenRA, and MatsuiR. Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization. Proc Natl Acad Sci USA, 113: 6011–6016, 2016.
177.
WenY-D, WangH, KhoS-H, RinkikoS, ShengX, ShenH-M, and ZhuY-Z. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One, 8: e53147, 2013.
178.
WeselerAR and BastA. Oxidative stress and vascular function: implications for pharmacologic treatments. Curr Hypertens Rep, 12: 154–161, 2010.
179.
WhitemanM, ArmstrongJS, ChuSH, Jia-LingS, WongB-S, CheungNS, HalliwellB, and MoorePK. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’?. J Neurochem, 90: 765–768, 2004.
180.
WinterbournCC and HamptonMB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med, 45: 549–561, 2008.
181.
WuQ, ZhaoB, WengY, ShanY, LiX, HuY, LiangZ, YuanH, ZhangL, and ZhangY. Site-specific quantification of persulfidome by combining an isotope-coded affinity tag with strong cation-exchange-based fractionation. Anal Chem, 91: 14860–14864, 2019.
182.
XiaoH, JedrychowskiMP, SchweppeDK, HuttlinEL, YuQ, HeppnerDE, LiJ, LongJ, MillsEL, SzpytJ, HeZ, DuG, GarrityR, ReddyA, VaitesLP, PauloJA, ZhangT, GrayNS, GygiSP, and ChouchaniET. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell, 180: 968–983.e24, 2020.
183.
XieL, GuY, WenM, ZhaoS, WangW, MaY, MengG, HanY, WangY, LiuG, MoorePK, WangX, WangH, ZhangZ, YuY, FerroA, HuangZ, and JiY. Hydrogen sulfide induces keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes, 65: 3171–3184, 2016.
184.
XiongY, UysJD, TewKD, and TownsendDM. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal, 15: 233–270, 2011.
185.
YanS-K, ChangT, WangH, WuL, WangR, and MengQH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun, 351: 485–491, 2006.
186.
YangG and WangR. H2S and blood vessels: an overview. Handb Exp Pharmacol, 230: 85–110, 2015.
187.
YangG, WuL, JiangB, YangW, QiJ, CaoK, MengQ, MustafaAK, MuW, ZhangS, SnyderSH, and WangR. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ gamma-lyase. Science, 322: 587–590, 2008.
188.
YangG, ZhaoK, JuY, ManiS, CaoQ, PuukilaS, KhaperN, WuL, and WangR. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal, 18: 1906–1919, 2013.
189.
YangJ, GuptaV, CarrollKS, and LieblerDC. Site-specific mapping and quantification of protein S-sulphenylation in cells. Nat Commun, 5: 4776, 2014.
190.
YangJ, GuptaV, TallmanKA, PorterNA, CarrollKS, and LieblerDC. Global, in situ, site-specific analysis of protein S-sulfenylation. Nat Protoc, 10: 1022–1037, 2015.
191.
YangJ, MinklerP, GroveD, WangR, WillardB, DweikR, and HineC. Non-enzymatic hydrogen sulfide production from cysteine in blood is catalyzed by iron and vitamin B6. Commun Biol, 2: 194, 2019.
192.
YangY, YinF, HangQ, DongX, ChenJ, LiL, CaoP, YinZ, and LuoL. Regulation of endothelial permeability by glutathione S-transferase Pi against actin polymerization. Cell Physiol Biochem, 45: 406–418, 2018.
193.
YouL-R, LinF-J, LeeCT, DeMayoFJ, TsaiM-J, and TsaiSY. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature, 435: 98–104, 2005.
